RTSN
RTSN clinical trials: Retension Pharmaceuticals, Inc.
Every trial on ClinicalTrials.gov where Retension Pharmaceuticals, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 3
- Trials linked
- 3
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
RTSN on the catalyst calendar · RTSN registry changes
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Mar 2027Sponsor estimate | NCT07142356A Study of Modified Release RTN-001 In Patients With Uncontrolled HypertensionRetension Pharmaceuticals. Inc. · Uncontrolled Hypertension | RTSNLead | Phase 2 | Recruiting | Locked | Locked | Locked |
| Dec 2007Actual | NCT00562614Safety and Effect of Oral Doses of 5mg or 10mg of SLx-2101 for 14 Days in Patients With HypertensionRetension Pharmaceuticals. Inc. · Hypertension | RTSNLead | Phase 2 | Completed | Locked | Locked | Locked |
| Dec 2007Actual | NCT00562549Safety and Effects of SLx-2101 Taken for up to 14 Days on Blood Pressure in Patients With HypertensionRetension Pharmaceuticals. Inc. · Hypertension | RTSNLead | Phase 2 | Completed | Locked | Locked | Locked |
- Primary completion Mar 2027Sponsor estimatePhase 2NCT07142356A Study of Modified Release RTN-001 In Patients With Uncontrolled HypertensionRetension Pharmaceuticals. Inc. · Uncontrolled HypertensionRecruitingRTSNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2007ActualPhase 2NCT00562614Safety and Effect of Oral Doses of 5mg or 10mg of SLx-2101 for 14 Days in Patients With HypertensionRetension Pharmaceuticals. Inc. · HypertensionCompletedRTSNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2007ActualPhase 2NCT00562549Safety and Effects of SLx-2101 Taken for up to 14 Days on Blood Pressure in Patients With HypertensionRetension Pharmaceuticals. Inc. · HypertensionCompletedRTSNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 3 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner